Tweet
So they have been testing an arthritis drug that's already approved and on the market in critical patients with covid-19 where the virus has spread to the lungs. This arthritis drug stops the overreaction of the immune system from damaging the lungs. Several people hours away from dying were given this arthritis drug for off label use and within days they were up and walking out of their beds...
The great thing about this is that it's already an approved drug. So we don't need year long trials and tests that are simply a day late and a dollar short for our current situation.
Full Article: https://www.wsj.com/articles/regener...nt-11583872762
The great thing about this is that it's already an approved drug. So we don't need year long trials and tests that are simply a day late and a dollar short for our current situation.
Boosting the rationale for studying Kevzara’s effect on Covid-19 was a recent report by Chinese researchers that a similar-acting drug, Actemra from Roche Holding AG , had helped a small group of patients with severe or critical Covid-19 disease recover.
Several patients in the study “got out of death’s bed and walked out of the hospital” after receiving Actemra, Dr. Yancopoulos said. However, he cautioned that the study required repeating because it was small, not controlled and didn’t have defined parameters for success.
Several patients in the study “got out of death’s bed and walked out of the hospital” after receiving Actemra, Dr. Yancopoulos said. However, he cautioned that the study required repeating because it was small, not controlled and didn’t have defined parameters for success.
Comment